BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

HemoShear, LLC Unveils in Vitro Steatosis System at Annual Meeting of the Association for the Study of Liver Diseases


11/8/2012 10:04:18 AM

CHARLOTTESVILLE, Va., Nov. 7, 2012 /PRNewswire/ -- HemoShear LLC, a biotechnology research company and leading developer of human and animal cell-based surrogate systems for discovery and assessment of new drug compounds, will present data on its transformational liver surrogate systems at The Liver Meeting 2012, the annual meeting of the American Association for the Study of Liver Diseases (AASLD) being held in Boston, Massachusetts, on November 9-13. AASLD is the world's leading organization of scientists and healthcare professionals committed to preventing and curing liver disease.

(Logo: http://photos.prnewswire.com/prnh/20120416/PH86899LOGO )

On Monday, November 12, from 8:00 a.m. to 5:00 p.m., HemoShear will present its innovative in vitro hepatic steatosis system. Visitors at the conference can view Abstract 1438 Development of an In-vitro Model of Hepatic Steatosis Using Rat Hepatocytes Under Controlled Hemodynamics in a Diabetic Milieu, Authored by HemoShear scientists Tye G. Deering, Joshua T. Thomas, Brett R. Blackman, Brian R. Wamhoff, and Ajit Dash.

For more information on the content of HemoShear's abstract, interested parties may visit the AASLD website at http://www.aasld.org/lm2012/2012/abstracts/Pages/default.aspx.

About HemoShear LLC
By applying physiologically accurate hemodynamics and biological transport to primary cell cultures, HemoShear creates human-relevant systems that accurately replicate the biology of organ systems and diseases throughout drug discovery and development. Working in strategic partnerships with pharmaceutical, biotechnology and medical device companies, HemoShear generates meaningful data to increase confidence in decision-making, reduce risk of costly failures and identify efficacious therapies. HemoShear's science leads to new medicines and improves human health.

SOURCE HemoShear LLC


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->